Torchmark (NYSE: TMK) is one of 38 publicly-traded companies in the “Life insurance” industry, but how does it compare to its rivals? We will compare Torchmark to similar companies based on the strength of its dividends, risk, earnings, institutional ownership, valuation, analyst recommendations and profitability.
Earnings & Valuation
This table compares Torchmark and its rivals gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Torchmark||$4.16 billion||$1.45 billion||17.78|
|Torchmark Competitors||$22.05 billion||$1.25 billion||16.12|
This table compares Torchmark and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider and Institutional Ownership
74.8% of Torchmark shares are held by institutional investors. Comparatively, 49.3% of shares of all “Life insurance” companies are held by institutional investors. 3.7% of Torchmark shares are held by company insiders. Comparatively, 18.8% of shares of all “Life insurance” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Torchmark pays an annual dividend of $0.64 per share and has a dividend yield of 0.7%. Torchmark pays out 13.3% of its earnings in the form of a dividend. As a group, “Life insurance” companies pay a dividend yield of 2.1% and pay out 28.7% of their earnings in the form of a dividend. Torchmark has increased its dividend for 8 consecutive years.
Risk & Volatility
Torchmark has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Torchmark’s rivals have a beta of 1.07, suggesting that their average stock price is 7% more volatile than the S&P 500.
This is a breakdown of current ratings and target prices for Torchmark and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Torchmark presently has a consensus price target of $82.25, suggesting a potential downside of 4.04%. As a group, “Life insurance” companies have a potential upside of 9.29%. Given Torchmark’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Torchmark has less favorable growth aspects than its rivals.
Torchmark rivals beat Torchmark on 8 of the 15 factors compared.
Torchmark Corporation (Torchmark) is an insurance holding company. The Company, through its subsidiaries, provides a range of life and health insurance products and annuities to a base of customers. The Company’s segments include life insurance, health insurance, annuities and investment. The life insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurance. The Health insurance products are guaranteed-renewable and include Medicare Supplement, critical illness, accident and limited-benefit supplemental hospital and surgical coverage’s. Annuities include fixed-benefit contracts. The Company markets its insurance products through various distribution channels, each of which sells the products of its insurance segments. Its subsidiaries include American Income Life Insurance Company (American Income) and Liberty National Life Insurance Company (Liberty National).
Receive News & Ratings for Torchmark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Torchmark and related companies with MarketBeat.com's FREE daily email newsletter.